Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Pliant Therapeutics Adopts Limited Duration Stockholder Rights Agreement In Response To Recent Accumulations Of Its Common Stock

Author: Benzinga Newsdesk | March 13, 2025 06:23am

The Rights Agreement will expire on March 11, 2026, or earlier, as provided in the Rights Agreement.

Under the Rights Agreement, the rights generally become exercisable if a person or a group of persons acquires beneficial ownership of 10% (or 20% in the case of certain investors filing on Schedule 13G) or more of the outstanding shares of Pliant common stock in a transaction not approved by the Board.

Posted In: PLRX


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist